Stephen C. Glover bought $25k of PDSB
director at PDS Biotechnology Corp. 15,061 shares at an average of $1.66, traded Feb 28, 2025, filed Mar 3, 2025.
Score components
- +15RoleDirector
- +5Trade size$25k at market
- +6Relative to holdingsHoldings up 24%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-006783, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | POpen-market purchase Common Stock | +15,061 | $1.66 | $25k | 78,851 | Mar 3, 2025 |
| Feb 28, 2025 | POpen-market purchase Common Warrantderivative | +15,061 | - | - | 15,061 | Mar 3, 2025 |
Related signals
Other insiders at PDS Biotechnology Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | PDS Biotechnology Corp | Gregory Gene Freitag director | $25k 15,060 shares | +33% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.